Cargando…
A common language to assess allergic rhinitis control: results from a survey conducted during EAACI 2013 Congress
BACKGROUND: The concept of control is gaining importance in the field of allergic rhinitis (AR), with a visual analogue scale (VAS) score being a validated, easy and attractive tool to evaluate AR symptom control. The doctors’ perception of a VAS score as a good tool for evaluating AR symptom contro...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4621924/ https://www.ncbi.nlm.nih.gov/pubmed/26509001 http://dx.doi.org/10.1186/s13601-015-0080-9 |
_version_ | 1782397521260183552 |
---|---|
author | Hellings, Peter W. Muraro, Antonella Fokkens, Wytske Mullol, Joaquim Bachert, Claus Canonica, G. Walter Price, David Papadopoulos, Nikos Scadding, Glenis Rasp, Gerd Demoly, Pascal Murray, Ruth Bousquet, Jean |
author_facet | Hellings, Peter W. Muraro, Antonella Fokkens, Wytske Mullol, Joaquim Bachert, Claus Canonica, G. Walter Price, David Papadopoulos, Nikos Scadding, Glenis Rasp, Gerd Demoly, Pascal Murray, Ruth Bousquet, Jean |
author_sort | Hellings, Peter W. |
collection | PubMed |
description | BACKGROUND: The concept of control is gaining importance in the field of allergic rhinitis (AR), with a visual analogue scale (VAS) score being a validated, easy and attractive tool to evaluate AR symptom control. The doctors’ perception of a VAS score as a good tool for evaluating AR symptom control is unknown, as is the level of AR control perceived by physicians who treat patients. METHODS: 307 voluntarily selected physicians attending the annual (2013) European Academy of Allergy and Clinical Immunology (EAACI) meeting completed a digital survey. Delegates were asked to (1) estimate how many AR patients/week they saw during the season, (2) estimate the proportion of patients they considered to have well-, partly- and un-controlled AR, (3) communicate how they gauged this control and (4) assess how useful they would find a VAS as a method of gauging control. 257 questionnaires were filled out completely and analysed. RESULTS: EAACI delegates reported seeing 46.8 [standard deviation (SD) 68.5] AR patients/week during the season. They estimated that 38.7 % (SD 24.0), 34.2 % (SD 20.2) and 20.0 % (SD 16.34) of their AR patients had well-controlled (no AR symptoms), partly-controlled (some AR symptoms), or un-controlled-(moderate/severe AR symptoms) disease despite taking medication [remainder unknown (7.1 %)]. However, AR control was assessed in many ways, including symptom severity (74 %), frequency of day- and night-time symptoms (67 %), activity impairment (57 %), respiratory function monitoring (nasal and/or lung function; 40 %) and incidence of AR exacerbations (50 %). 91 % of delegates felt a simple VAS would be a useful tool to gauge AR symptom control. CONCLUSIONS: A substantial portion of patients with AR are perceived as having uncontrolled or partly controlled disease even when treated. A simple VAS score is considered a useful tool to monitor AR control. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13601-015-0080-9) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-4621924 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-46219242015-10-28 A common language to assess allergic rhinitis control: results from a survey conducted during EAACI 2013 Congress Hellings, Peter W. Muraro, Antonella Fokkens, Wytske Mullol, Joaquim Bachert, Claus Canonica, G. Walter Price, David Papadopoulos, Nikos Scadding, Glenis Rasp, Gerd Demoly, Pascal Murray, Ruth Bousquet, Jean Clin Transl Allergy Research BACKGROUND: The concept of control is gaining importance in the field of allergic rhinitis (AR), with a visual analogue scale (VAS) score being a validated, easy and attractive tool to evaluate AR symptom control. The doctors’ perception of a VAS score as a good tool for evaluating AR symptom control is unknown, as is the level of AR control perceived by physicians who treat patients. METHODS: 307 voluntarily selected physicians attending the annual (2013) European Academy of Allergy and Clinical Immunology (EAACI) meeting completed a digital survey. Delegates were asked to (1) estimate how many AR patients/week they saw during the season, (2) estimate the proportion of patients they considered to have well-, partly- and un-controlled AR, (3) communicate how they gauged this control and (4) assess how useful they would find a VAS as a method of gauging control. 257 questionnaires were filled out completely and analysed. RESULTS: EAACI delegates reported seeing 46.8 [standard deviation (SD) 68.5] AR patients/week during the season. They estimated that 38.7 % (SD 24.0), 34.2 % (SD 20.2) and 20.0 % (SD 16.34) of their AR patients had well-controlled (no AR symptoms), partly-controlled (some AR symptoms), or un-controlled-(moderate/severe AR symptoms) disease despite taking medication [remainder unknown (7.1 %)]. However, AR control was assessed in many ways, including symptom severity (74 %), frequency of day- and night-time symptoms (67 %), activity impairment (57 %), respiratory function monitoring (nasal and/or lung function; 40 %) and incidence of AR exacerbations (50 %). 91 % of delegates felt a simple VAS would be a useful tool to gauge AR symptom control. CONCLUSIONS: A substantial portion of patients with AR are perceived as having uncontrolled or partly controlled disease even when treated. A simple VAS score is considered a useful tool to monitor AR control. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13601-015-0080-9) contains supplementary material, which is available to authorized users. BioMed Central 2015-10-27 /pmc/articles/PMC4621924/ /pubmed/26509001 http://dx.doi.org/10.1186/s13601-015-0080-9 Text en © Hellings et al. 2015 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Hellings, Peter W. Muraro, Antonella Fokkens, Wytske Mullol, Joaquim Bachert, Claus Canonica, G. Walter Price, David Papadopoulos, Nikos Scadding, Glenis Rasp, Gerd Demoly, Pascal Murray, Ruth Bousquet, Jean A common language to assess allergic rhinitis control: results from a survey conducted during EAACI 2013 Congress |
title | A common language to assess allergic rhinitis control: results from a survey conducted during EAACI 2013 Congress |
title_full | A common language to assess allergic rhinitis control: results from a survey conducted during EAACI 2013 Congress |
title_fullStr | A common language to assess allergic rhinitis control: results from a survey conducted during EAACI 2013 Congress |
title_full_unstemmed | A common language to assess allergic rhinitis control: results from a survey conducted during EAACI 2013 Congress |
title_short | A common language to assess allergic rhinitis control: results from a survey conducted during EAACI 2013 Congress |
title_sort | common language to assess allergic rhinitis control: results from a survey conducted during eaaci 2013 congress |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4621924/ https://www.ncbi.nlm.nih.gov/pubmed/26509001 http://dx.doi.org/10.1186/s13601-015-0080-9 |
work_keys_str_mv | AT hellingspeterw acommonlanguagetoassessallergicrhinitiscontrolresultsfromasurveyconductedduringeaaci2013congress AT muraroantonella acommonlanguagetoassessallergicrhinitiscontrolresultsfromasurveyconductedduringeaaci2013congress AT fokkenswytske acommonlanguagetoassessallergicrhinitiscontrolresultsfromasurveyconductedduringeaaci2013congress AT mulloljoaquim acommonlanguagetoassessallergicrhinitiscontrolresultsfromasurveyconductedduringeaaci2013congress AT bachertclaus acommonlanguagetoassessallergicrhinitiscontrolresultsfromasurveyconductedduringeaaci2013congress AT canonicagwalter acommonlanguagetoassessallergicrhinitiscontrolresultsfromasurveyconductedduringeaaci2013congress AT pricedavid acommonlanguagetoassessallergicrhinitiscontrolresultsfromasurveyconductedduringeaaci2013congress AT papadopoulosnikos acommonlanguagetoassessallergicrhinitiscontrolresultsfromasurveyconductedduringeaaci2013congress AT scaddingglenis acommonlanguagetoassessallergicrhinitiscontrolresultsfromasurveyconductedduringeaaci2013congress AT raspgerd acommonlanguagetoassessallergicrhinitiscontrolresultsfromasurveyconductedduringeaaci2013congress AT demolypascal acommonlanguagetoassessallergicrhinitiscontrolresultsfromasurveyconductedduringeaaci2013congress AT murrayruth acommonlanguagetoassessallergicrhinitiscontrolresultsfromasurveyconductedduringeaaci2013congress AT bousquetjean acommonlanguagetoassessallergicrhinitiscontrolresultsfromasurveyconductedduringeaaci2013congress AT hellingspeterw commonlanguagetoassessallergicrhinitiscontrolresultsfromasurveyconductedduringeaaci2013congress AT muraroantonella commonlanguagetoassessallergicrhinitiscontrolresultsfromasurveyconductedduringeaaci2013congress AT fokkenswytske commonlanguagetoassessallergicrhinitiscontrolresultsfromasurveyconductedduringeaaci2013congress AT mulloljoaquim commonlanguagetoassessallergicrhinitiscontrolresultsfromasurveyconductedduringeaaci2013congress AT bachertclaus commonlanguagetoassessallergicrhinitiscontrolresultsfromasurveyconductedduringeaaci2013congress AT canonicagwalter commonlanguagetoassessallergicrhinitiscontrolresultsfromasurveyconductedduringeaaci2013congress AT pricedavid commonlanguagetoassessallergicrhinitiscontrolresultsfromasurveyconductedduringeaaci2013congress AT papadopoulosnikos commonlanguagetoassessallergicrhinitiscontrolresultsfromasurveyconductedduringeaaci2013congress AT scaddingglenis commonlanguagetoassessallergicrhinitiscontrolresultsfromasurveyconductedduringeaaci2013congress AT raspgerd commonlanguagetoassessallergicrhinitiscontrolresultsfromasurveyconductedduringeaaci2013congress AT demolypascal commonlanguagetoassessallergicrhinitiscontrolresultsfromasurveyconductedduringeaaci2013congress AT murrayruth commonlanguagetoassessallergicrhinitiscontrolresultsfromasurveyconductedduringeaaci2013congress AT bousquetjean commonlanguagetoassessallergicrhinitiscontrolresultsfromasurveyconductedduringeaaci2013congress |